<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Martini MC</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Directorate for Biological Sciences</funding><funding>NIAID NIH HHS</funding><pagination>e1010705</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9312406</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(7)</volume><pubmed_abstract>Despite the existence of well-characterized, canonical mutations that confer high-level drug resistance to Mycobacterium tuberculosis (Mtb), there is evidence that drug resistance mechanisms are more complex than simple acquisition of such mutations. Recent studies have shown that Mtb can acquire non-canonical resistance-associated mutations that confer survival advantages in the presence of certain drugs, likely acting as stepping-stones for acquisition of high-level resistance. Rv2752c/rnj, encoding RNase J, is disproportionately mutated in drug-resistant clinical Mtb isolates. Here we show that deletion of rnj confers increased tolerance to lethal concentrations of several drugs. RNAseq revealed that RNase J affects expression of a subset of genes enriched for PE/PPE genes and stable RN</pubmed_abstract><journal>PLoS pathogens</journal><pubmed_title>Loss of RNase J leads to multi-drug tolerance and accumulation of highly structured mRNA fragments in Mycobacterium tuberculosis.</pubmed_title><pmcid>PMC9312406</pmcid><funding_grant_id>5TP01AI143575-02</funding_grant_id><funding_grant_id>P01 AI143575</funding_grant_id><funding_grant_id>U19 AI107774</funding_grant_id><funding_grant_id>1652756</funding_grant_id><pubmed_authors>Martini MC</pubmed_authors><pubmed_authors>Sixsmith J</pubmed_authors><pubmed_authors>Alonso MN</pubmed_authors><pubmed_authors>Barbier T</pubmed_authors><pubmed_authors>Fortune SM</pubmed_authors><pubmed_authors>Xiao J</pubmed_authors><pubmed_authors>Shell SS</pubmed_authors><pubmed_authors>Hicks ND</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of RNase J leads to multi-drug tolerance and accumulation of highly structured mRNA fragments in Mycobacterium tuberculosis.</name><description>Despite the existence of well-characterized, canonical mutations that confer high-level drug resistance to Mycobacterium tuberculosis (Mtb), there is evidence that drug resistance mechanisms are more complex than simple acquisition of such mutations. Recent studies have shown that Mtb can acquire non-canonical resistance-associated mutations that confer survival advantages in the presence of certain drugs, likely acting as stepping-stones for acquisition of high-level resistance. Rv2752c/rnj, encoding RNase J, is disproportionately mutated in drug-resistant clinical Mtb isolates. Here we show that deletion of rnj confers increased tolerance to lethal concentrations of several drugs. RNAseq revealed that RNase J affects expression of a subset of genes enriched for PE/PPE genes and stable RN</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2026-05-27T20:12:26.553Z</modification><creation>2024-11-08T16:45:31.447Z</creation></dates><accession>S-EPMC9312406</accession><cross_references><pubmed>35830479</pubmed><doi>10.1371/journal.ppat.1010705</doi></cross_references></HashMap>